南京医药：关于公司参与设立南京新工南药医疗器械强链并购股权投资有限责任公司并对外投资暨关联交易的公告

Core Viewpoint - Nanjing Medical Pharmaceutical Company plans to invest in a new medical device investment company, indicating a strategic move to enhance its investment portfolio in the healthcare sector [2] Group 1: Investment Details - The company intends to invest 11.98 million RMB, which represents 59.9% of the total subscribed capital of the newly established Nanjing New Industry Medical Device Investment Company [2] - The investment will specifically target Ningbo Jiangfeng Biological Information Technology Co., Ltd., with an overall valuation not exceeding 750 million RMB for the acquisition of approximately 22.5% equity [2] - The final transaction price and key investment terms will be determined by a formal equity investment agreement [2] Group 2: Related Parties and Governance - The investment involves related parties, as Nanjing New Industry Investment Group Co., Ltd., the controlling shareholder of the company, fully owns Nanjing New Industry Investment Management Co., Ltd. [2] - The investment has been approved by the company's board of directors and does not require shareholder meeting approval [2]